APO Research
Talk to an analyst

APO RESEARCH · REPORT

Procalcitonin

Procalcitonin (PCT), CAS 56645-65-9, is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Procalcitonin (PCT), CAS 56645-65-9, is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli

Selected research

Market Structure

Global Procalcitonin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

9 January 2026193 pages

Choose your research edition.

Industry ResearchProcalcitonin Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Procalcitonin Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Procalcitonin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Procalcitonin Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Procalcitonin Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

Procalcitonin (PCT), CAS 56645-65-9, is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli

Global Procalcitonin (CAS 56645-65-9) key players include Thermo Fisher, bioMerieux, BBI Solutions, Roche Diagnostics, HyTest, etc. Global top five manufacturers hold a share about 35%. Asia Pacific and Europe is the largest market, both with a share about 30%, followed by North America, with a share about 25 percent. In terms of product, Procalcitonin Antigen is the largest segment, with a share about 80%. And in terms of application, the largest application is Medical Industry, followed by Scientific Research, and Veterinarian.

This report provides an overview of the global Procalcitonin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Procalcitonin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Procalcitonin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Procalcitonin market size, projected growth trends, production technologies, key applications, and end-use industries.

Procalcitonin Segment by Company

Thermo Fisher

Roche Diagnostics

bioMerieux

HyTest

BBI Solutions

ProSpec

Wondfo

Ningbo Medicalsystem Biotechnology

Wuhan Easy Diagnosis Biomedicine

Snibe

Vazyme Biotech

Getein Biotech

Hotgen Biotech

Lumigenex

Nanjing Norman Biological Technology

Kitgen

Beijing KeyGen

Beijing Apis

Procalcitonin Segment by Type

Procalcitonin Antigen

Procalcitonin Antibody

Procalcitonin Segment by Application

Medical Industry

Scientific Research

Veterinarian

Procalcitonin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Procalcitonin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Procalcitonin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Procalcitonin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Procalcitonin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Procalcitonin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Procalcitonin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Procalcitonin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Procalcitonin Industry Trends Table 2. Procalcitonin Industry Drivers Table 3. Procalcitonin Industry Opportunities and Challenges Table 4. Procalcitonin Industry Restraints Table 5. Global Procalcitonin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Procalcitonin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Procalcitonin Sales by Manufacturers (mg) & (2021-2026) Table 8. Global Procalcitonin Sales Market Share by Manufacturers Table 9. Global Procalcitonin Average Sales Price (USD/mg) of Manufacturers (2021-2026) Table 10. Global Procalcitonin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Procalcitonin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Procalcitonin Manufacturers, Product Type & Application Table 13. Global Procalcitonin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Procalcitonin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Procalcitonin Antigen Table 17. Major Manufacturers of Procalcitonin Antibody Table 18. Global Procalcitonin Sales by Type 2021 VS 2025 VS 2032 (mg) Table 19. Global Procalcitonin Sales by Type (2021-2026) & (mg) Table 20. Global Procalcitonin Sales by Type (2027-2032) & (mg) Table 21. Global Procalcitonin Sales Market Share by Type (2021-2026) Table 22. Global Procalcitonin Sales Market Share by Type (2027-2032) Table 23. Global Procalcitonin Revenue by Type 2021 VS 2025 VS 2032 (mg) Table 24. Global Procalcitonin Revenue by Type (2021-2026) & (mg) Table 25. Global Procalcitonin Revenue by Type (2027-2032) & (mg) Table 26. Global Procalcitonin Revenue Market Share by Type (2021-2026) Table 27. Global Procalcitonin Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Medical Industry Table 29. Major Manufacturers of Scientific Research Table 30. Major Manufacturers of Veterinarian Table 31. Global Procalcitonin Sales by Application 2021 VS 2025 VS 2032 (mg) Table 32. Global Procalcitonin Sales by Application (2021-2026) & (mg) Table 33. Global Procalcitonin Sales by Application (2027-2032) & (mg) Table 34. Global Procalcitonin Sales Market Share by Application (2021-2026) Table 35. Global Procalcitonin Sales Market Share by Application (2027-2032) Table 36. Global Procalcitonin Revenue by Application 2021 VS 2025 VS 2032 (mg) Table 37. Global Procalcitonin Revenue by Application (2021-2026) & (mg) Table 38. Global Procalcitonin Revenue by Application (2027-2032) & (mg) Table 39. Global Procalcitonin Revenue Market Share by Application (2021-2026) Table 40. Global Procalcitonin Revenue Market Share by Application (2027-2032) Table 41. Global Procalcitonin Sales by Region: 2021 VS 2025 VS 2032 (mg) Table 42. Global Procalcitonin Sales by Region (2021-2026) & (mg) Table 43. Global Procalcitonin Sales Market Share by Region (2021-2026) Table 44. Global Procalcitonin Sales Forecasted by Region (2027-2032) & (mg) Table 45. Global Procalcitonin Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Procalcitonin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (mg) Table 47. North America Procalcitonin Sales by Country (2021-2026) & (mg) Table 48. North America Procalcitonin Sales by Country (2027-2032) & (mg) Table 49. Europe Procalcitonin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (mg) Table 50. Europe Procalcitonin Sales by Country (2021-2026) & (mg) Table 51. Europe Procalcitonin Sales by Country (2027-2032) & (mg) Table 52. Asia Pacific Procalcitonin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (mg) Table 53. Asia Pacific Procalcitonin Sales by Country (2021-2026) & (mg) Table 54. Asia Pacific Procalcitonin Sales by Country (2027-2032) & (mg) Table 55. South America, Middle East and Africa Procalcitonin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (mg) Table 56. South America, Middle East and Africa Procalcitonin Sales by Country (2021-2026) & (mg) Table 57. South America, Middle East and Africa Procalcitonin Sales by Country (2027-2032) & (mg) Table 58. Global Procalcitonin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Procalcitonin Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Procalcitonin Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Procalcitonin Revenue Market Share by Region (2021-2026) Table 62. Global Procalcitonin Revenue Market Share by Region (2027-2032) Table 63. Thermo Fisher Company Information Table 64. Thermo Fisher Business Overview Table 65. Thermo Fisher Procalcitonin Sales (mg), Price (USD/mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Thermo Fisher Procalcitonin Product Portfolio Table 67. Thermo Fisher Recent Development Table 68. Roche Diagnostics Company Information Table 69. Roche Diagnostics Business Overview Table 70. Roche Diagnostics Procalcitonin Sales (mg), Price (USD/mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Roche Diagnostics Procalcitonin Product Portfolio Table 72. Roche Diagnostics Recent Development Table 73. bioMerieux Company Information Table 74. bioMerieux Business Overview Table 75. bioMerieux Procalcitonin Sales (mg), Price (USD/mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. bioMerieux Procalcitonin Product Portfolio Table 77. bioMerieux Recent Development Table 78. HyTest Company Information Table 79. HyTest Business Overview Table 80. HyTest Procalcitonin Sales (mg), Price (USD/mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. HyTest Procalcitonin Product Portfolio Table 82. HyTest Recent Development Table 83. BBI Solutions Company Information Table 84. BBI Solutions Business Overview Table 85. BBI Solutions Procalcitonin Sales (mg), Price (USD/mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. BBI Solutions Procalcitonin Product Portfolio Table 87. BBI Solutions Recent Development Table 88. ProSpec Company Information Table 89. ProSpec Business Overview Table 90. ProSpec Procalcitonin Sales (mg), Price (USD/mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. ProSpec Procalcitonin Product Portfolio Table 92. ProSpec Recent Development Table 93. Wondfo Company Information Table 94. Wondfo Business Overview Table 95. Wondfo Procalcitonin Sales (mg), Price (USD/mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Wondfo Procalcitonin Product Portfolio Table 97. Wondfo Recent Development Table 98. Ningbo Medicalsystem Biotechnology Company Information Table 99. Ningbo Medicalsystem Biotechnology Business Overview Table 100. Ningbo Medicalsystem Biotechnology Procalcitonin Sales (mg), Price (USD/mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Ningbo Medicalsystem Biotechnology Procalcitonin Product Portfolio Table 102. Ningbo Medicalsystem Biotechnology Recent Development Table 103. Wuhan Easy Diagnosis Biomedicine Company Information Table 104. Wuhan Easy Diagnosis Biomedicine Business Overview Table 105. Wuhan Easy Diagnosis Biomedicine Procalcitonin Sales (mg), Price (USD/mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Wuhan Easy Diagnosis Biomedicine Procalcitonin Product Portfolio Table 107. Wuhan Easy Diagnosis Biomedicine Recent Development Table 108. Snibe Company Information Table 109. Snibe Business Overview Table 110. Snibe Procalcitonin Sales (mg), Price (USD/mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Snibe Procalcitonin Product Portfolio Table 112. Snibe Recent Development Table 113. Vazyme Biotech Company Information Table 114. Vazyme Biotech Business Overview Table 115. Vazyme Biotech Procalcitonin Sales (mg), Price (USD/mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Vazyme Biotech Procalcitonin Product Portfolio Table 117. Vazyme Biotech Recent Development Table 118. Getein Biotech Company Information Table 119. Getein Biotech Business Overview Table 120. Getein Biotech Procalcitonin Sales (mg), Price (USD/mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Getein Biotech Procalcitonin Product Portfolio Table 122. Getein Biotech Recent Development Table 123. Hotgen Biotech Company Information Table 124. Hotgen Biotech Business Overview Table 125. Hotgen Biotech Procalcitonin Sales (mg), Price (USD/mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Hotgen Biotech Procalcitonin Product Portfolio Table 127. Hotgen Biotech Recent Development Table 128. Lumigenex Company Information Table 129. Lumigenex Business Overview Table 130. Lumigenex Procalcitonin Sales (mg), Price (USD/mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Lumigenex Procalcitonin Product Portfolio Table 132. Lumigenex Recent Development Table 133. Nanjing Norman Biological Technology Company Information Table 134. Nanjing Norman Biological Technology Business Overview Table 135. Nanjing Norman Biological Technology Procalcitonin Sales (mg), Price (USD/mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Nanjing Norman Biological Technology Procalcitonin Product Portfolio Table 137. Nanjing Norman Biological Technology Recent Development Table 138. Kitgen Company Information Table 139. Kitgen Business Overview Table 140. Kitgen Procalcitonin Sales (mg), Price (USD/mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Kitgen Procalcitonin Product Portfolio Table 142. Kitgen Recent Development Table 143. Beijing KeyGen Company Information Table 144. Beijing KeyGen Business Overview Table 145. Beijing KeyGen Procalcitonin Sales (mg), Price (USD/mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Beijing KeyGen Procalcitonin Product Portfolio Table 147. Beijing KeyGen Recent Development Table 148. Beijing Apis Company Information Table 149. Beijing Apis Business Overview Table 150. Beijing Apis Procalcitonin Sales (mg), Price (USD/mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Beijing Apis Procalcitonin Product Portfolio Table 152. Beijing Apis Recent Development Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Procalcitonin Distributors List Table 156. Procalcitonin Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Procalcitonin Product Image Figure 2. Global Procalcitonin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Procalcitonin Market Size (2021-2032) & (US$ Million) Figure 4. Global Procalcitonin Sales (2021-2032) & (mg) Figure 5. Global Procalcitonin Average Price (USD/mg) & (2021-2032) Figure 6. Global Top 5 and 10 Procalcitonin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Procalcitonin Antigen Image Figure 9. Procalcitonin Antibody Image Figure 10. Global Procalcitonin Sales by Type (2021 VS 2025 VS 2032) & (mg) Figure 11. Global Procalcitonin Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Procalcitonin Sales Market Share by Type (2021-2032) Figure 13. Global Procalcitonin Revenue by Type (2021 VS 2025 VS 2032) & (mg) Figure 14. Global Procalcitonin Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Procalcitonin Revenue Market Share by Type (2021-2032) Figure 16. Medical Industry Image Figure 17. Scientific Research Image Figure 18. Veterinarian Image Figure 19. Global Procalcitonin Sales by Application (2021 VS 2025 VS 2032) & (mg) Figure 20. Global Procalcitonin Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Procalcitonin Sales Market Share by Application (2021-2032) Figure 22. Global Procalcitonin Revenue by Application (2021 VS 2025 VS 2032) & (mg) Figure 23. Global Procalcitonin Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Procalcitonin Revenue Market Share by Application (2021-2032) Figure 25. North America Procalcitonin Sales and Growth Rate (2021-2032) & (mg) Figure 26. North America Procalcitonin Sales Market Share by Country (2021-2032) Figure 27. U.S. Procalcitonin Sales and Growth Rate (2021-2032) & (mg) Figure 28. Canada Procalcitonin Sales and Growth Rate (2021-2032) & (mg) Figure 29. Mexico Procalcitonin Sales and Growth Rate (2021-2032) & (mg) Figure 30. Europe Procalcitonin Sales and Growth Rate (2021-2032) & (mg) Figure 31. Europe Procalcitonin Sales Market Share by Country (2021-2032) Figure 32. Germany Procalcitonin Sales and Growth Rate (2021-2032) & (mg) Figure 33. France Procalcitonin Sales and Growth Rate (2021-2032) & (mg) Figure 34. U.K. Procalcitonin Sales and Growth Rate (2021-2032) & (mg) Figure 35. Italy Procalcitonin Sales and Growth Rate (2021-2032) & (mg) Figure 36. Netherlands Procalcitonin Sales and Growth Rate (2021-2032) & (mg) Figure 37. Asia Pacific Procalcitonin Sales and Growth Rate (2021-2032) & (mg) Figure 38. Asia Pacific Procalcitonin Sales Market Share by Country (2021-2032) Figure 39. China Procalcitonin Sales and Growth Rate (2021-2032) & (mg) Figure 40. Japan Procalcitonin Sales and Growth Rate (2021-2032) & (mg) Figure 41. South Korea Procalcitonin Sales and Growth Rate (2021-2032) & (mg) Figure 42. Southeast Asia Procalcitonin Sales and Growth Rate (2021-2032) & (mg) Figure 43. India Procalcitonin Sales and Growth Rate (2021-2032) & (mg) Figure 44. Australia Procalcitonin Sales and Growth Rate (2021-2032) & (mg) Figure 45. South America, Middle East and Africa Procalcitonin Sales and Growth Rate (2021-2032) & (mg) Figure 46. South America, Middle East and Africa Procalcitonin Sales Market Share by Country (2021-2032) Figure 47. Brazil Procalcitonin Sales and Growth Rate (2021-2032) & (mg) Figure 48. South Africa Procalcitonin Sales and Growth Rate (2021-2032) & (mg) Figure 49. Saudi Arabia Procalcitonin Sales and Growth Rate (2021-2032) & (mg) Figure 50. Turkey Procalcitonin Sales and Growth Rate (2021-2032) & (mg) Figure 51. Argentina Procalcitonin Sales and Growth Rate (2021-2032) & (mg) Figure 52. UAE Procalcitonin Sales and Growth Rate (2021-2032) & (mg) Figure 53. Egypt Procalcitonin Sales and Growth Rate (2021-2032) & (mg) Figure 54. Chile Procalcitonin Sales and Growth Rate (2021-2032) & (mg) Figure 55. Global Procalcitonin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Procalcitonin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Procalcitonin Revenue (2021-2032) & (US$ Million) Figure 58. North America Procalcitonin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Procalcitonin Revenue (2021-2032) & (US$ Million) Figure 60. Europe Procalcitonin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Procalcitonin Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Procalcitonin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Procalcitonin Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Procalcitonin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Procalcitonin Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Procalcitonin Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Procalcitonin Antigen
  • Procalcitonin Antibody
Applications
  • Medical Industry
  • Scientific Research
  • Veterinarian
Companies covered
  • Thermo Fisher
  • Roche Diagnostics
  • bioMerieux
  • HyTest
  • BBI Solutions
  • ProSpec
  • Wondfo
  • Ningbo Medicalsystem Biotechnology
  • Wuhan Easy Diagnosis Biomedicine
  • Snibe
  • Vazyme Biotech
  • Getein Biotech
  • Hotgen Biotech
  • Lumigenex
  • Nanjing Norman Biological Technology
  • Kitgen
  • Beijing KeyGen
  • Beijing Apis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Procalcitonin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Procalcitonin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Procalcitonin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Procalcitonin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Procalcitonin Market Dynamics
  1. 2.1 Procalcitonin Industry Trends
  2. 2.2 Procalcitonin Industry Drivers
  3. 2.3 Procalcitonin Industry Opportunities and Challenges
  4. 2.4 Procalcitonin Industry Restraints
3 Procalcitonin Market by Manufacturers
  1. 3.1 Global Procalcitonin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Procalcitonin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Procalcitonin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Procalcitonin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Procalcitonin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Procalcitonin Manufacturers, Product Type & Application
  7. 3.7 Global Procalcitonin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Procalcitonin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Procalcitonin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Procalcitonin Tier 1, Tier 2, and Tier 3
4 Procalcitonin Market by Type
  1. 4.1 Procalcitonin Type Introduction
  2. 4.1.1 Procalcitonin Antigen
  3. 4.1.2 Procalcitonin Antibody
  4. 4.2 Global Procalcitonin Sales by Type
  5. 4.2.1 Global Procalcitonin Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Procalcitonin Sales by Type (2021-2032)
  7. 4.2.3 Global Procalcitonin Sales Market Share by Type (2021-2032)
  8. 4.3 Global Procalcitonin Revenue by Type
  9. 4.3.1 Global Procalcitonin Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Procalcitonin Revenue by Type (2021-2032)
  11. 4.3.3 Global Procalcitonin Revenue Market Share by Type (2021-2032)
5 Procalcitonin Market by Application
  1. 5.1 Procalcitonin Application Introduction
  2. 5.1.1 Medical Industry
  3. 5.1.2 Scientific Research
  4. 5.1.3 Veterinarian
  5. 5.2 Global Procalcitonin Sales by Application
  6. 5.2.1 Global Procalcitonin Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Procalcitonin Sales by Application (2021-2032)
  8. 5.2.3 Global Procalcitonin Sales Market Share by Application (2021-2032)
  9. 5.3 Global Procalcitonin Revenue by Application
  10. 5.3.1 Global Procalcitonin Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Procalcitonin Revenue by Application (2021-2032)
  12. 5.3.3 Global Procalcitonin Revenue Market Share by Application (2021-2032)
6 Global Procalcitonin Sales by Region
  1. 6.1 Global Procalcitonin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Procalcitonin Sales by Region (2021-2032)
  3. 6.2.1 Global Procalcitonin Sales by Region (2021-2026)
  4. 6.2.2 Global Procalcitonin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Procalcitonin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Procalcitonin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Procalcitonin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Procalcitonin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Procalcitonin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Procalcitonin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Procalcitonin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Procalcitonin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Procalcitonin Revenue by Region
  1. 7.1 Global Procalcitonin Revenue by Region
  2. 7.1.1 Global Procalcitonin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Procalcitonin Revenue by Region (2021-2026)
  4. 7.1.3 Global Procalcitonin Revenue by Region (2027-2032)
  5. 7.1.4 Global Procalcitonin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Procalcitonin Revenue (2021-2032)
  8. 7.2.2 North America Procalcitonin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Procalcitonin Revenue (2021-2032)
  11. 7.3.2 Europe Procalcitonin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Procalcitonin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Procalcitonin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Procalcitonin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Procalcitonin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher
  2. 8.1.1 Thermo Fisher Company Information
  3. 8.1.2 Thermo Fisher Business Overview
  4. 8.1.3 Thermo Fisher Procalcitonin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Procalcitonin Product Portfolio
  6. 8.1.5 Thermo Fisher Recent Developments
  7. 8.2 Roche Diagnostics
  8. 8.2.1 Roche Diagnostics Company Information
  9. 8.2.2 Roche Diagnostics Business Overview
  10. 8.2.3 Roche Diagnostics Procalcitonin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Roche Diagnostics Procalcitonin Product Portfolio
  12. 8.2.5 Roche Diagnostics Recent Developments
  13. 8.3 bioMerieux
  14. 8.3.1 bioMerieux Company Information
  15. 8.3.2 bioMerieux Business Overview
  16. 8.3.3 bioMerieux Procalcitonin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 bioMerieux Procalcitonin Product Portfolio
  18. 8.3.5 bioMerieux Recent Developments
  19. 8.4 HyTest
  20. 8.4.1 HyTest Company Information
  21. 8.4.2 HyTest Business Overview
  22. 8.4.3 HyTest Procalcitonin Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 HyTest Procalcitonin Product Portfolio
  24. 8.4.5 HyTest Recent Developments
  25. 8.5 BBI Solutions
  26. 8.5.1 BBI Solutions Company Information
  27. 8.5.2 BBI Solutions Business Overview
  28. 8.5.3 BBI Solutions Procalcitonin Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 BBI Solutions Procalcitonin Product Portfolio
  30. 8.5.5 BBI Solutions Recent Developments
  31. 8.6 ProSpec
  32. 8.6.1 ProSpec Company Information
  33. 8.6.2 ProSpec Business Overview
  34. 8.6.3 ProSpec Procalcitonin Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 ProSpec Procalcitonin Product Portfolio
  36. 8.6.5 ProSpec Recent Developments
  37. 8.7 Wondfo
  38. 8.7.1 Wondfo Company Information
  39. 8.7.2 Wondfo Business Overview
  40. 8.7.3 Wondfo Procalcitonin Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Wondfo Procalcitonin Product Portfolio
  42. 8.7.5 Wondfo Recent Developments
  43. 8.8 Ningbo Medicalsystem Biotechnology
  44. 8.8.1 Ningbo Medicalsystem Biotechnology Company Information
  45. 8.8.2 Ningbo Medicalsystem Biotechnology Business Overview
  46. 8.8.3 Ningbo Medicalsystem Biotechnology Procalcitonin Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Ningbo Medicalsystem Biotechnology Procalcitonin Product Portfolio
  48. 8.8.5 Ningbo Medicalsystem Biotechnology Recent Developments
  49. 8.9 Wuhan Easy Diagnosis Biomedicine
  50. 8.9.1 Wuhan Easy Diagnosis Biomedicine Company Information
  51. 8.9.2 Wuhan Easy Diagnosis Biomedicine Business Overview
  52. 8.9.3 Wuhan Easy Diagnosis Biomedicine Procalcitonin Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Wuhan Easy Diagnosis Biomedicine Procalcitonin Product Portfolio
  54. 8.9.5 Wuhan Easy Diagnosis Biomedicine Recent Developments
  55. 8.10 Snibe
  56. 8.10.1 Snibe Company Information
  57. 8.10.2 Snibe Business Overview
  58. 8.10.3 Snibe Procalcitonin Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Snibe Procalcitonin Product Portfolio
  60. 8.10.5 Snibe Recent Developments
  61. 8.11 Vazyme Biotech
  62. 8.11.1 Vazyme Biotech Company Information
  63. 8.11.2 Vazyme Biotech Business Overview
  64. 8.11.3 Vazyme Biotech Procalcitonin Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Vazyme Biotech Procalcitonin Product Portfolio
  66. 8.11.5 Vazyme Biotech Recent Developments
  67. 8.12 Getein Biotech
  68. 8.12.1 Getein Biotech Company Information
  69. 8.12.2 Getein Biotech Business Overview
  70. 8.12.3 Getein Biotech Procalcitonin Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Getein Biotech Procalcitonin Product Portfolio
  72. 8.12.5 Getein Biotech Recent Developments
  73. 8.13 Hotgen Biotech
  74. 8.13.1 Hotgen Biotech Company Information
  75. 8.13.2 Hotgen Biotech Business Overview
  76. 8.13.3 Hotgen Biotech Procalcitonin Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hotgen Biotech Procalcitonin Product Portfolio
  78. 8.13.5 Hotgen Biotech Recent Developments
  79. 8.14 Lumigenex
  80. 8.14.1 Lumigenex Company Information
  81. 8.14.2 Lumigenex Business Overview
  82. 8.14.3 Lumigenex Procalcitonin Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Lumigenex Procalcitonin Product Portfolio
  84. 8.14.5 Lumigenex Recent Developments
  85. 8.15 Nanjing Norman Biological Technology
  86. 8.15.1 Nanjing Norman Biological Technology Company Information
  87. 8.15.2 Nanjing Norman Biological Technology Business Overview
  88. 8.15.3 Nanjing Norman Biological Technology Procalcitonin Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Nanjing Norman Biological Technology Procalcitonin Product Portfolio
  90. 8.15.5 Nanjing Norman Biological Technology Recent Developments
  91. 8.16 Kitgen
  92. 8.16.1 Kitgen Company Information
  93. 8.16.2 Kitgen Business Overview
  94. 8.16.3 Kitgen Procalcitonin Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Kitgen Procalcitonin Product Portfolio
  96. 8.16.5 Kitgen Recent Developments
  97. 8.17 Beijing KeyGen
  98. 8.17.1 Beijing KeyGen Company Information
  99. 8.17.2 Beijing KeyGen Business Overview
  100. 8.17.3 Beijing KeyGen Procalcitonin Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Beijing KeyGen Procalcitonin Product Portfolio
  102. 8.17.5 Beijing KeyGen Recent Developments
  103. 8.18 Beijing Apis
  104. 8.18.1 Beijing Apis Company Information
  105. 8.18.2 Beijing Apis Business Overview
  106. 8.18.3 Beijing Apis Procalcitonin Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Beijing Apis Procalcitonin Product Portfolio
  108. 8.18.5 Beijing Apis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Procalcitonin Value Chain Analysis
  2. 9.1.1 Procalcitonin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Procalcitonin Production Mode & Process
  6. 9.2 Procalcitonin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Procalcitonin Distributors
  9. 9.2.3 Procalcitonin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst